Alector to present new data from frontotemporal dementia and alzheimer's disease programs at the 2021 alzheimer's association international conference

Oral presentation to highlight data from the ongoing phase 2 study of al001 in ftd-grn company to host analyst and investor conference call on july 29 at 1:00 p.m. et
ALEC Ratings Summary
ALEC Quant Ranking